Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults

Summary

Phase I/II, open, prospective clinical trial, historically controlled. The objective is to evaluate the safety and, as a secondary measure, the efficacy of an experimental treatment based on a cellular therapy (vaccination with autologous dendritic cells pulsed with tumor lysate) in patients affected of metastatic or relapsed sarcomas or (Central Nervous System) CNS tumors.

Timeline

Start

2014-09-30

Primary completion

2018-09-16

Completion

2019-05-27

Drugs

Indications